Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

STICKY SUGARS

Financiado

Sweet adhesins: Probing bacterial glycoproteins with novel tools to inspire futu...

Sweet adhesins: Probing bacterial glycoproteins with novel tools to inspire future antibacterial strategies With bacteria increasingly resistant to current antibiotics, new strategies to fight infection are needed. Bacterial adhesin proteins, which play an important role in the establishment of infection, appear to be promising targets... ver más

30/04/2028

RIJKSUNIVERSITEIT...

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

RIJKSUNIVERSITEIT GRONINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-02-01

ERC-2022-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

RIJKSUNIVERSITEIT GRONINGEN

1.50M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PATHO-LEGO All-in-one supramolecular approach as an innovative anti-inf... 150K€ Cerrado

RTI2018-099985-B-I00 ESTUDIO DE LA GLICOSILACION DE EXOSOMAS CIRCULANTES Y BACTER... 151K€ Cerrado

PDC2021-121544-I00 DISEÑO DE UNA NUEVA CLASE DE ANTIMICROBIANOS CONTRA INFECCIO... 133K€ Cerrado

NovAnI Indentification and optimisation of novel anti infective age... 1M€ Cerrado

PID2021-125801OB-I00 ESTUDIO DEL METABOLISMO DEL ADN Y LAS BIOPELICULAS POLIMICRO... 182K€ Cerrado

PID2020-112612GB-I00 COMPRENSION DE LA FUNCION DE QUIMIORRECEPTORES EN BACTERIAS... 290K€ Cerrado

Duración del proyecto: 62 meses Fecha Inicio: 2023-02-01
Fecha Fin: 2028-04-30

Líder del proyecto

RIJKSUNIVERSITEIT GRONINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto With bacteria increasingly resistant to current antibiotics, new strategies to fight infection are needed. Bacterial adhesin proteins, which play an important role in the establishment of infection, appear to be promising targets for novel therapies. Adhesins enable the first contact between bacteria and host cells. We know that some adhesins are modified with highly unique sugars that are important for adhesin stability and adherence. However, we do not know how widespread this modification is, and whether it constitutes a good target for antibacterial strategies. A lack of suitable methods for the detection of bacterial adhesin sugars has impeded the detailed study of these sugars, blocking further efforts to develop antibacterial strategies against bacterial adhesin sugars. In this project, I aim to revolutionize our understanding of adhesin sugars, in terms of timing and prevalence of the modification, which is crucial information to start targeting adhesin sugars. To this end, I have designed an innovative approach that combines the strengths of carbohydrate chemistry, enzymology, microbiology and molecular dynamics to 1) establish straightforward methods to selectively visualize and quantify the adhesin sugars directly on the surface of bacterial cells; 2) detect the presence of adhesin sugars under changing growth conditions and in relevant clinical isolates; and 3) develop a computational method to predict the presence of sugars on adhesins that have not yet been identified. Recent findings from my team on the process of adhesin modification underscore the uniqueness of adhesin sugars, and this experience puts me in an ideal position to start this project. The overarching goal of STICKY SUGARS is to lay the foundation for the exploitation of adhesin sugars as antibacterial targets. By visualizing adhesin sugars directly on bacteria, we can observe their response to antibacterial treatments and pave the way toward clinical applications in the future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores